Despite the prevalence of uterine fibroids (Fs), few studies have investigated the links between clinical features and the cellular or molecular mechanisms that drive F growth and development. Such knowledge will ultimately help to differentiate symptomatic from asymptomatic Fs and could result in the development of more effective and individualized treatments. The aim of this study was to investigate the relationship between ultrasound appearance, blood flow, and angiogenic gene expression in F, perifibroid (PM), and distant myometrial (DM) tissues. We hypothesized that angiogenic gene expression would be increased in tissues and participants that showed increased blood flow by Doppler ultrasound. The study was performed using Doppler ultrasound to measure blood flow prior to hysterectomy, with subsequent tissue samples from the F, PM, and DM being investigated for angiogenic gene expression. Overall, PM blood flow (measured as peak systolic velocity [PSV]) was higher than F blood flow, although significant heterogeneity was seen in vascularity and blood flow between different Fs and their surrounding myometrium. We did not find any correlation between PSV and any other clinical or molecular parameter in this study. We identified 19 angiogenesis pathway-related genes with significant differences in expression between F and DM, and 2 genes, matrix metalloproteinase 9 (MMP9) and Neuropilin 2 (NRP2), that were significantly different between F and PM. These results are consistent with subtle differences between PM and DM. Understanding the differences between symptomatic versus asymptomatic Fs may eventually lead to more effective treatments that directly target the source of heavy menstrual bleeding.
Day BairdDDunsonDBHillMCCousinsDSchectmanJM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107.
2.
CramerSFPatelA. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435–438.
FaulknerRL. The blood vessels of the myomatous uterus. Am J Obstet Gynaecol. 1944;47:185–197.
11.
WestonGTrajstmanACGargettCEManuelpillaiUVollenhovenBJRogersPA. Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. Mol Hum Reprod. 2003;9(9):541–549.
12.
SampsonJ. The influence of myomata on the blood supply of the uterus, with special reference to abnormal uterine bleeding. Surg Gynecol Obstet. 1912;16:144–180.
13.
TsibrisJCSegarsJCoppolaDInsights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril. 2002;78(1):114–121.
14.
AhnWSKimKWBaeSMTargeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis. Int J Exp Pathol. 2003;84(6):267–279.
15.
QuadeBJWangTYSornbergerKDal CinPMutterGLMortonCC. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes Chromosomes Cancer. 2004;40(2):97–108.
16.
ArslanAAGoldLIMittalKGene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod. 2005;20(4):852–863.
17.
LeeEJKongGLeeSHProfiling of differentially expressed genes in human uterine leiomyomas. Int J Gynecol Cancer. 2005;15(1):146–154.
18.
VanharantaSWorthamNC, Laiho P, et al. 7q deletion mapping and expression profiling in uterine fibroids. Oncogene. 2005;24(43):6545–6554.
19.
ZaitsevaMVollenhovenBJRogersPA.In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells. Mol Hum Reprod. 2006;12(3):187–207.
20.
ZaitsevaMVollenhovenBJRogersPA. Retinoids regulate genes involved in retinoic acid synthesis and transport in human myometrial and fibroid smooth muscle cells. Hum Reprod. 2008;23(5):1076–1086.
21.
Bodner-AdlerBNatherABodnerKExpression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study. Gynecol Oncol. 2006;103(1):186–189.
22.
BeheraMAFengLYonishBCatherinoWJungSHLeppertP. Thrombospondin-1 and thrombospondin-2 mRNA and TSP-1 and TSP-2 protein expression in uterine fibroids and correlation to the genes COL1A1 and COL3A1 and to the collagen cross-link hydroxyproline. Reprod Sci. 2007;14(8 suppl):63–76.
23.
IwahashiMMuragakiY. Increased type I and V collagen expression in uterine leiomyomas during the menstrual cycle. Fertil Steril. 2011;95(6):2137–2139.
24.
LeppertPCCatherinoWHSegarsJH. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol. 2006;195(2):415–420.
25.
CheginiN. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin Reprod Med. 2010;28(3):180–203.
26.
WolanskaMSobolewskiKBankowskiEJaworskiS. Matrix metalloproteinases of human leiomyoma in various stages of tumor growth. Gynecol Obstet Invest. 2004;58(1):14–18.
27.
BogusiewiczMStryjecka-ZimmerMPostawskiKJakimiukAJRechbergerT. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium. Gynecol Endocrinol. 2007;23(9):541–546.
28.
JiangYSuoGSadaranganiACowanBWangJY. Expression profiling of protein tyrosine kinases and their ligand activators in leiomyoma uteri. Syst Biol Reprod Med. 2010;56(4):318–326.
29.
CaseyRRogersPAVollenhovenBJ. An immunohistochemical analysis of fibroid vasculature. Hum Reprod. 2000;15(7):1469–1475.
30.
BrauerMM. Cellular and molecular mechanisms underlying plasticity in uterine sympathetic nerves. Auton Neurosci. 2008;140(1-2):1–16.
31.
AugustinHGKohGYThurstonGAlitaloK. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol. 2009;10(3):165–177.
32.
BagriATessier-LavigneMWattsRJ. Neuropilins in tumor biology. Clin Cancer Res. 2009;15(6):1860–1864.
33.
BhuvaneswariRGanYYLuckySSMolecular profiling of angiogenesis in hypericin mediated photodynamic therapy. Mol Cancer. 2008;7:56.
34.
ShimomuraYMatsuoHSamotoTMaruoT. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J Clin Endocrinol Metab. 1998;83(6):2192–2198.
35.
WangJOharaNWangZA novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells. Hum Reprod. 2006;21(7):1869–1877.
36.
WolanskaMBankowskiE. Fibroblast growth factors (FGF) in human myometrium and uterine leiomyomas in various stages of tumour growth. Biochimie. 2006;88(2):141–146.
37.
LiangMWangHZhangYLuSWangZ. Expression and functional analysis of platelet-derived growth factor in uterine leiomyomata. Cancer Biol Ther. 2006;5(1):28–33.
38.
TsaiFCLiuWMPaiMHHsiehMSLinJYChouCM. Downregulation of the integrin alpha(v) signaling pathway in uterine leiomyomas. Gynecol Obstet Invest. 2011;71(2):129–135.
39.
HuyenDVBanyBM. Evidence for a conserved function of heart and neural crest derivatives expressed transcript 2 in mouse and human decidualization. Reproduction. 2011;142(2):353–368.
40.
YamamotoYOlsonDMvan BennekomMBrindleyDNHemmingsDG. Increased expression of enzymes for sphingosine 1-phosphate turnover and signaling in human decidua during late pregnancy. Biol Reprod. 2010;82(3):628–635.
41.
ChenLFanRHuangXXuHZhangX. Decreased concentrations of pigment epithelium-derived factor in peritoneal fluid of patients with endometriosis. Fertil Steril. 2011;95(5):1798–1800.
42.
DueholmMLundorfESorensenJSLedertougSOlesenFLaursenH. Reproducibility of evaluation of the uterus by transvaginal sonography, hysterosonographic examination, hysteroscopy and magnetic resonance imaging. Hum Reprod. 2002;17(1):195–200.
